ArticleJHLT open2026
Racial, ethnic, and sex disparities in lung transplant waitlist outcomes before and after composite allocation score implementation.
Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lung transplantation in 2025: a narrative review of progress, challenges, and the road ahead.Journal of thoracic disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: We aimed to evaluate if known racial, ethnic, and sex disparities in lung transplant waitlist outcomes with the Lung Allocation Score (LAS) persist with implementation of the Composite Allocation Score (CAS). Methods: We performed a retrospective cohort study of the Scientific Registry of Transplant Recipients (SRTR) database, examining waitlist outcomes of all adult patients listed for lung transplantation in the United States from January 2018 to March 2024, comparing patients listed in the LAS (1/1/2018-9/9/2022) or CAS (3/9/23-3/24/24) eras. Results: Black candidates had a lower likelihood of transplantation (LAS sHR: 0.85, 95% CI: 0.79-0.91, p<0.001; CAS sHR: 0.81, 0.71-0.93, p=0.002) compared to White candidates in both eras, and a greater likelihood of waitlist removal (sHR: 2.31, 1.35-3.95, p=0.003) in the CAS era. Female candidates had lower rates of transplantation compared to male candidates in both eras (LAS sHR: 0.75, 0.71-0.80, p<0.001; CAS sHR: 0.88, 0.79-0.98, p=0.017). There were no significant differences in extracorporeal membrane oxygenation (ECMO) or mechanical ventilation while listed between race/ethnicity in the CAS era. Female candidates had lower odds of ECMO in both eras (LAS OR: 0.74, CI: 0.58-0.95, p=0.019; CAS OR: 0.53, 0.30-0.96, p=0.037). Black candidates had a greater hazard of waitlist removal due to "other" reasons compared to White candidates in both eras (LAS sHR: 1.75, 1.27-2.42, p<0.001; CAS sHR: 2.06, 1.17-3.61, p=0.013). Conclusion: Disparities in lung transplant waitlist outcomes are improved but persist in the CAS era. These disparities warrant further investigation into ways to provide more equitable access to lung transplantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.